Parnassus Investments
ELV icon

Parnassus Investments’s Elevance Health ELV Stock Holding History

Parnassus Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-400,000
Closed -$76M – 89
2017
Q3 		$76M Sell
400,000
-200,000
-33% -$38.1M 0.31% 60
2017
Q2 		$113M Hold
600,000
– – 0.48% 50
2017
Q1 		$99.2M Buy
600,000
+25,000
+4% +$3.98M 0.46% 47
2016
Q4 		$82.7M Buy
575,000
+425,000
+283% +$56.9M 0.41% 48
2016
Q3 		$18.8M Buy
+150,000
New +$19.4M 0.1% 68

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Parnassus Investments's ELV Position: Q4 2017 in Review

Parnassus Investments sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 400,000 shares — an estimated $76M sold.

Parnassus Investments first reported a position in ELV in Q3 2016 and held it in 5 quarters. The position peaked at $113M in Q2 2017. 910 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • Parnassus Investments reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
  • Parnassus Investments sold 400,000 Elevance Health shares in Q4 2017, an estimated $76M.
  • Parnassus Investments first reported a position in Elevance Health in Q3 2016 and held it in 5 quarters.
  • Parnassus Investments's Elevance Health position peaked at $113M in Q2 2017.
  • 910 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Parnassus Investments's 13F filing for Q4 2017, filed 5 Feb 2018.